OLMA
Olema Pharmaceuticals Inc
NASDAQ: OLMA · HEALTHCARE · BIOTECHNOLOGY
$14.41
+1.91% today
Updated 2026-04-30
Market cap
$1.23B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.87
Dividend yield
—
52W range
$4 – $36
Volume
1.6M
Olema Pharmaceuticals Inc (OLMA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.18M | $-3.08M | $-19.87M | $-50.69M | $-82.06M | $-83.73M | $-104.35M | $-146.72M |
| Capital expenditures | $56000.00 | $56000.00 | $56000.00 | $1.57M | $363000.00 | $0.00 | $159000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $1000.00 | $0.00 | $3.11M | $15.91M | $18.83M | $17.26M | $22.58M | $17.59M |
| Free cash flow | $-2.23M | $-3.14M | $-19.92M | $-52.27M | $-82.43M | $-83.73M | $-104.51M | $-146.72M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $3.09M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-324.74M | $9.89M | — | — | — |